Prostate Cancer News on BioPortfolio

J&J files next generation prostate cancer drug in Europe

After having filed its new prostate cancer drug apalutamide with the FDA in October Johnson & Johnson have now submitted the drug to Europes EMA.The drug is very significant for J&Js pharma division not least because a court recently ...

Updates in metastatic prostate cancer

Professor Heather Payne Dr Neal Shore Dr Eleni Efstathiou and Professor Nicolas Mottet discuss the management of patients with metastatic hormone sensitive prostate cancer mHSPC and the anticipated impact the data presented at the 2018 ASCO...

Updates on nonmetastatic castrationresistant prostate cancer

Professor Kurt Miller chairs a discussion with Professor Silke Gillessen Professor Heather Payne and Dr Eric Small on the latest data presented at the 2018 ASCO Genitourinary Cancers SymposiumÂin San Francisco with a focus on the treatment of patients...

FDA Approves CastrationSensitive Prostate Cancer Drug

Officials with the FDA have granted approval to abiraterone acetate Zytiga tablets in combination with prednisone for the treatment of metastatic highrisk castrationsensitive prostate cancer CSPC according to a press release.